Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Who cares! Monster being born!! Get on the right side. Big things coming
People will be blown away by this in the coming months
Zero reference to pred in this video link
Everyone is focused on stem cells with pred. While that is where their revenue is now, their real value will come from their gene platform and identity illnesses much much sooner thus allowing for quicker preventative treatments
Like everything else, I’m sure it will be announced . There’s a lot of work that goes into a product launch and it’s important that given the sensitivity’s around this product that they take their time and do it right
Yes. That’s been the case for the last few Pars
It’s not! It’s just peoples naive expectations.
The clock started to tick on June 3rd norm after that is 60 working days.
Still in the window. Nasdaq works at its own pace. They look after IPOs, secondary’s etc first, then pred will get slotted in
Agreed. All this BS down here will be forgotten. This is just the labor pains of a finer being borne
That’s my point!
They are the world leaders!
They have the largest database on the planet of disease gene data. This is why people are wiring up to do business here. They can predict disease based in that database! The secret is in the name ! Predictive technology.
This news today was peer reviewed and accepted by the largest group of its kind in the US ASRM. It’s huge. 3 new unique findings!
And now they are licking the patents down.
“Patent applications have been filed around these new discoveries adding to the Company’s robust endometriosis patent portfolio”
And this is just endometriosis. This will also apply to preeclampsia per PR Wednesday and a host of other diseases
Guess ASRM didn’t read the memo!! http://asrm-2019.org/
Another totally credible organization. Biggest in the US.
Here’s the important line on the PR
“Three scientific presentations (two oral and one poster) highlighting recent discoveries by Predictive Laboratories were selected through ASRM’s scientific peer-review process. “
ASRM reviewed the new findings and approved the presentations.
https://www.nasdaq.com/press-release/predictive-laboratories-to-present-new-endometriosis-discoveries-in-three-presentations-at-leading-20190802-00408
I’m am Spartacus!
Here comes the bus.. watch out!!
You’re 100% correct.
The upside here is that anything gates funds and as such anything they is associated would receive a high degree of scrutiny this eliminating all the aspersions that arose from the Hindenburg piece. It’s further validation that this is the real deal if it was needed
Interesting first 5 mins. Zero trades. No sellers
To me he is the bull version of Hindenburg. All hype and no fact. Both equally dangerous
He’s irrelevant and during this fall in pps he disappeared when his people needed him. His predictions have been continuously wrong so I wouldn’t even be bringing his predictions here as they add nothing to the board. He’s entertaining in a parody type way but anyone listening to him has been badly served here
Couple of interesting points on this PR plus everything any newbies might not know
https://finance.yahoo.com/news/predictive-laboratories-announces-research-collaboration-162513169.html
Preeclampsia registry will request 2500 samples from all over the world. Pred already has 20,000 such samples.
The aim is to develop a proprietary test kit as it’s a huge worldwide problem effecting 3-8% of the world female population.
“. The study will advance the Preeclampsia Foundation’s database of collected preeclampsia medical information and will be utilized by Predictive Laboratories to develop a proprietary test for the early detection of women at risk for preeclampsia.”
“ Preeclampsia affects 5-8%, or approximately 300,000, pregnancies every year in the United States, sometimes causing severe adverse maternal and fetal outcomes, including organ failure, massive blood loss, permanent disability or even death. Globally, preeclampsia is a leading cause of pregnancy complications, preterm births and related disabilities. The deaths of approximately 76,000 mothers and 500,000 babies annually are attributable to preeclampsia. Healthcare providers, even in medically advanced countries, are hampered by imprecise diagnostic tools.“
Backed by doctors from Harvard, Berkeley and the Gates foundation https://www.preeclampsiaregistry.org/about-us
So now we have pred involved in endometriosis testing and treatments (multi billion $ field) preeclampsia (multi billion $ area) about to run a fda trail with IQvia of treatment of knee pain. About to do something on scoliosis (stem cell based) generating significant growing revenues, launched cellsure (another multi billion $ field) entered into a deal with ThermoFisher, has a who’s who of big pharma involved in management and board of directors, has the top legal company in the world Wilson Sonsini dealing with everything, with much more to come.
All you need to know about pred. Forget the noise, stay focused on the fundamentals and where this company is going.
Pred attorneys who facilitated all the m&a in the company .https://bestlawfirms.usnews.com/profile/wilson-sonsini-goodrich-rosati-pc-llo/rankings/13129
Small Outfit !!
The Auditors BF Borgers rank number 7 in the entire country dealing with otc ! Deloitte are number 6 and KPMG are number 8!
https://blog.auditanalytics.com/who-audits-public-companies-2019-edition/
Relative comparison pred v adpt
Similar but not exact business but very comparable
Pred revenue projected $55m
Adpt rev $55m https://craft.co/adaptive-biotechnologies/metrics
Adpt market cap $5b
Pred market cap $700m
Adpt revenue multiple 100x
Pred revenue multiple 12x
Adpt on nasdaq
Pred on way to nasdaq
Pps adpt $39
Pps pred $1-60
Number of products adpt 1
Number of products pred multiple
Adpt partners Microsoft
Pred IQVIA and ThermoFisher
Employees adpt 300
Employees pred 200 and growing
Only difference is time. It’s going to happen
Here’s everything else on pred
A example of real world values in this field is adpt which just did an iPo and has a $6B market cap and a $40 share price. It has less revenue, relies on one product and the team is a shadow of the team in pred.It has about 10% of what pred has!
zacks did a full review https://s1.q4cdn.com/460208960/files/News/2019/Zacks_SCR_Research_06112019_PRED_Vandermosten.pdf
Have to add cellsure to this now https://parentsguidecordblood.org/en/news/cellsure-brings-disruptive-innovation-banking-stem-cells
The U.S. Cord Blood Banking (CBB) services market was valued over USD 17.2 billion in 2016 and is expected to reach over USD 49.09 billion at CAGR of around 12.2% during the forecast period. High awareness regarding benefits of cord blood (CB), tissue, and placenta storage coupled with increasing number of service providers offering services at competitive prices are the factors driving the market growth.
Companyy at world conferences releasing new data to the best in the world. http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/ Then TMO, one of the largest biotechs in the world does a partnership with them. Who do you think knows more! http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
Let’s look at the team, ex execs from Pfizer, ING, Wyatt, ex president of the American Medical Association, one of the leading senators over the last 100 years and the list goes on. http://predtechgroup.com/about/
The leading attorneys when it comes to biotech Wilson sonsini (they probably have a good idea what’s going on internally) https://www.wsgr.com/WSGR/Display.aspx?SectionName=about the ex senior counsel and ex president of nasdaq is leading their Nasdaq uplist process.https://www.donohoeadvisory.com/about-us/david-a-donohoe-jr/
Let’s also look at the fundamentals
Form 10 passed 30 days ago! If any of this article was remotely true then the would never have passed sec scrutiny and got their form 10! https://www.sec.gov/Archives/edgar/data/1382943/000000000019009260/filename2.txt
Revenues growing q over q! I’m assuming this Q will be the same.
IQVIA (multi billion dollar company) leading one of their fda trials http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
Major partnership with ThermoFisher
As I always say, do your homework and know what you own
All the recent press and it’s extensive
http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/
http://predtechgroup.com/2019/06/predictive-technology-group-names-industry-veteran-dr-douglas-rabin-vice-president-of-medical-affairs-womens-health-of-predictive-laboratories/
http://predtechgroup.com/2019/05/predictive-technology-group-announces-enrollment-milestone-of-200-participants-in-predictive-laboratories-study-for-chronic-joint-and-spine-pain/
http://predtechgroup.com/2019/04/predictive-technology-group-names-christine-seward-senior-vice-president-of-sales-and-marketing-of-predictive-laboratories/
http://predtechgroup.com/press/
Only in the future will we all realize how lucky we were to be here at the beginning
Great post and on point. As I repeatedly say, people have no idea as to the magnitude of this company. This company is 10 years ahead of anything in the disease indicating space. This is an important distinction. The reason tmo, preeclampsia foundation etc is hitching their very substantial wagons to pred is because they have more indicative and predictive data than anyone else on the planet. That’s the magic sauce that everyone is missing and it’s not just for one disease. They cover a multitude with more to come. This is the bluest of blue chips in the space and watch it blossom.
A lot to come boys and girls
This is a huge world wide collaboration and puts pred into every fertility clinic in the world. This is a multi focused health company. Time will show this to be the best platform company in the space
Here comes the bus !! Run shorty
It wouldn’t be surprising. This will and us the biggest company in the sector and it will be valued as such soo
Also Harvard and Berkeley. More experts fooled. Here comes the bus
The only strategy that works is delivering results . Today’s news huge as there’s no way you get a deal with Gates behind it without getting a real going over. Looks like the company fooled another major guy along with COzo of pfe and tmo!! Folks you just need to believe this is going to explode. This is a monster
I don’t believe there is any quote period. I’m assuming they feel that news is more impactful when on nasdaq which has hurt us short term. I don’t believe they are hung up on share price. They aren’t raising money and are much more focused on building the company and the pps will follow.
Also I think people’s expectations on nasdaq are skewed. Form 10 approval on June 3. Clock started from then and it normally takes up to 60 days for the process. We are right in the red zone over the next 2 weeks so I’m thinking we get bees shortly
For anyone thinking that the space is y changing, check out the recent moves and the associated valuations. $50B to $100B is chump change
https://www.google.com/amp/s/amp.ft.com/content/267f06cc-b0aa-11e9-bec9-fdcab53d6959
Feel free, when it’s posted it’s fair game
Somebody on a pm asked me about valuations and what makes sense here on pred. I’ll do my best to give you my thoughts. (I don’t do PMs here)
First and foremost and I don’t mean this to be in anyway disparaging to anyone, I don’t believe most of you truly know what this company is. I think that is the company’s fault and also people not truly understanding the space.
Most here are talking about stem cell treatments and endometriosis which is where the company is making its current and short term future revenues. These in their own right make the company a multi million $ company based on numbers and I think we will see that unfold over the next 12 months. That’s all good.
The real secret sauce here is their gene data base which is light years ahead of anyone in the space. They have been collecting for over 20 years, long before anyone else got into the game. Why is this important?
https://www.washingtonpost.com/news/theworldpost/wp/2017/12/13/human-genome/?noredirect=on&utm_term=.248831c6ed45
The future of medicine is going to be gene platform based and most of the future work in medicine is going to be based around this. In my opinion pred has the number one platform on the planet and as such the value is astronomical. For example 23 and me has a $1.8B valuation https://www.cnbc.com/2018/05/22/23andme-2018-disruptor-50.html with a fraction of data they pred has.
Adpt has a 2.5B market cap and only focused on one area, nvta 2.5B market cap again with limited capacity and focus.
I believe pred as it unfolds will be working with multiple big pharma (pfe has a colab with 23 and me) who are all in this space and looking for the right fit. Pred is that fit. To date pred publicly is working in endometriosis, stem cell treatments for knees, back and has launched cellsure. Rumors abound of major colabs in cancer, heart, and other major diseases.
What does all this mean re valuation? Pick a number but on a personal level I believe over the coming years it will be north of $30b and I could be really wrong as it could be much more. Time will tell but this is only the start and pred hasn’t even told the world properly what they are. All the big pharma guys are here for a reason
You can call it whatever you want but it’s irrelevant. Company will execute and value will be realized. Up or down now isn’t important to me personally but I do realize that it is annoying if you bought higher.
Fundamentals improving, that’s the important piece. Drift is down to lack of news and low volume. When it turns it will run hard.
Again, this is the curse of the otc. Nobody has any patience’s. So used to crap stocks spiking and running that nobody thinks like a real investor who u sweatbands that a good company is like a good wine, it takes time and news doesn’t just come out to keep i hub posters happy. It comes when it’s due. 100% comfortable here but I accept that if I bought higher, it’s hard to look st
Real smart guys know they aren’t the smartest in the room but each to their own. I’m sure the company will take your comments on board given you have an MBA
You’re entitled to your opinion but smarter people than you and I are working in this so I would sssume they would know best
They addressed it perfectly. Why give it air! I’m sure it’s being addressed in other ways that don’t have to be broadcast on message boards to keep
A few shareholders happy!
Anyone have a look at nvta? 2.3b market cap and pred light years ahead of them in multiple fields. Interesting, Hindenburg and Nate who wrote the hit report is actively promoting nvta!
The printed rules as you put it have been repeatedly posted on here and it clearly states multiple routes that do not require $4. I’m only pointing that out as it’s important to be clear as there’s enough “Fake” info floating about. My point is that none of this matters as nasdaq have total discretion as to what flies and last time I checked, none of us worked there!
The company can only control what it does and continue to execute. Nasdaq will come when it’s ready. Control the controllables.
You’re all wrong so I wouldn’t sweat it. Nasdaq will do what they deem fit so all the speculation in the world is irrelevant. Nasdaq will come when it’s ready. The company can’t control that. All they can do is continue to execute on their fundamentals and run the company which I believe is happening. Everything g else will follow suit. The Nasdaq when it comes will be appreciated but it will mean nothing without the company executing.
That’s 100% more important
Dont know where you get the $4 number but it’s incorrect
60m a year run rate, revenues increasing daily,partnered with one of the largest biotechs in the world, but some guy on the message board knows better than then how to run the company and what they need. Any of you guys have a number for the company and tell them if they are hiring, there’s an abundance of experts here under newly formed aliases
Now you’re getting it. This is a mega company and it’s only starting it’s journey
I’ve always said that the more you dig here the better it gets.
Here’s everything you need to know for now but this will be a multi product biotech doing billions in revenue. It will have multiple trials on various illnesses and their cures. I believe there will be multiple partnerships like the TMO deal and that this will be worth billions of dollars.
Predictive Technolog (PRED)
2.77 ? 0.27 (10.80%)
Volume: 47,493 @07/19/19 9:53:21 AM EDT
Bid Ask Day's Range
2.73 2.78 2.55 - 2.77
PRED Detailed Quote
1D
1M
2M
3M
6M
1Y
2Y
3Y
5Y
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 5/22/2019 5:24:40 PM
Amended Securities Registration (section 12(g)) (10-12g/a) Edgar (US Regulatory) - 5/22/2019 5:12:12 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/21/2019 2:53:51 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/20/2019 4:53:10 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/15/2019 4:50:11 PM
Amended Securities Registration (section 12(g)) (10-12g/a) Edgar (US Regulatory) - 4/22/2019 4:02:48 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/15/2019 11:43:56 AM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 4/12/2019 3:42:53 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 4/12/2019 2:58:59 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/12/2019 1:14:26 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/12/2019 1:09:35 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/12/2019 1:05:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/12/2019 7:59:17 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/12/2019 7:53:56 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/12/2019 7:48:45 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/12/2019 7:42:04 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/25/2019 4:03:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/19/2019 4:20:55 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 3/1/2019 4:04:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/1/2019 3:58:54 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/27/2019 7:10:24 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/26/2019 4:17:42 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/26/2019 4:15:34 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/26/2019 1:36:52 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/26/2019 1:32:10 PM
stockguru1971 Thursday, 07/18/19 04:20:55 AM
Re: None 0
Post # of 9059
For anyone new here
All you need to know about pred. Forget the noise, stay focused on the fundamentals and where this company is going.
Pred attorneys who facilitated all the m&a in the company .https://bestlawfirms.usnews.com/profile/wilson-sonsini-goodrich-rosati-pc-llo/rankings/13129
Small Outfit !!
The Auditors who have had their name dragged through the mud BF Borgers rank number 7 in the entire country dealing with otc ! Deloitte are number 6 and KPMG are number 8!
https://blog.auditanalytics.com/who-audits-public-companies-2019-edition/
Relative comparison pred v adpt
Similar but not exact business but very comparable
Pred revenue projected $55m
Adpt rev $55m https://craft.co/adaptive-biotechnologies/metrics
Adpt market cap $5b
Pred market cap $700m
Adpt revenue multiple 100x
Pred revenue multiple 12x
Adpt on nasdaq
Pred on way to nasdaq
Pps adpt $39
Pps pred $1-60
Number of products adpt 1
Number of products pred multiple
Adpt partners Microsoft
Pred IQVIA and ThermoFisher
Employees adpt 300
Employees pred 200 and growing
Only difference is time. It’s going to happen
Here’s everything else on pred
I know there’s a lot of excitement with this “big hitter” going after Hindenburg and the “shorts” and that’s great but it doesn’t help you today other than making you feel a bit better and having a white knight ride to your aid. It’s not important. The important things are listed below and the company fundamentals are continuing to improve.
One of our would be experts has pulled distorted financials out to validate his doomsday scenario. The company is surrounded by deep pockets, has never gone into the market for money and is cash flowing with increasing revenues, building out new facilities and hiring world class team.
A example of real world values in this field is adpt which just did an iPo and has a $6B market cap and a $40 share price. It has less revenue, relies on one product and the team is a shadow of the team in pred.It has about 10% of what pred has! This will be proven out.
Everyone would have loved to sell at $6-90 and buy back yesterday but 1% do that. You are not stupid. It’s the way it is. The company is legit, the people are legit and the relationships are legit. Don’t get caught in the short sighted daily game. Do you’re own homework, I’ve taken a lot of the work out of it for you below. It’s easy to fool one big guy into joining you but you can’t fool the best of the best in the medical world, pfe, tmo, as well as the best Kesha’s minds Wilson sonsini (their partner joined the board) , the top Nasdaq guys, form 10 through the second and also zacks did a full review https://s1.q4cdn.com/460208960/files/News/2019/Zacks_SCR_Research_06112019_PRED_Vandermosten.pdf
This will end and recover and we still have one of the best companies on the street and this will be proven out
Here’s the only thing that matters
Have to add cellsure to this now https://parentsguidecordblood.org/en/news/cellsure-brings-disruptive-innovation-banking-stem-cells
The U.S. Cord Blood Banking (CBB) services market was valued over USD 17.2 billion in 2016 and is expected to reach over USD 49.09 billion at CAGR of around 12.2% during the forecast period. High awareness regarding benefits of cord blood (CB), tissue, and placenta storage coupled with increasing number of service providers offering services at competitive prices are the factors driving the market growth.
Here’s my 2 cents for what’s it’s worth
Classic bear raid and attack piece by this Hindenburg group that clearly states he’s short!
“Hindenburg Research (possibly along with or through our members, partners, affiliates, employees, and/or consultants) along with our clients and/or investors has a short position in all stocks (and/or options of the stock) covered herein, and therefore stands to realize significant gains in the event that the price of any stock covered herein declines. ”
Look at the logic here, the article was totally biased and used info that was completely incorrect to spook people and it worked.
Ex chairman (ex being the key) had sec issues. False and as shown elsewhere they were dropped so therefore no issues.
Company procedures and process are a fraud and don’t work, yet they are at world conferences releasing new data to the best in the world. http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/ Then TMO, one of the largest biotechs in the world does a partnership with them. Who do you think knows more! http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
Let’s look at the team, ex execs from Pfizer, ING, Wyatt, ex president of the American Medical Association, one of the leading senators over the last 100 years and the list goes on. http://predtechgroup.com/about/
The leading attorneys when it comes to biotech Wilson sonsini (they probably have a good idea what’s going on internally) https://www.wsgr.com/WSGR/Display.aspx?SectionName=about the ex senior counsel and ex president of nasdaq is leading their Nasdaq uplist process.https://www.donohoeadvisory.com/about-us/david-a-donohoe-jr/
Let’s also look at the fundamentals
Form 10 passed 30 days ago! If any of this article was remotely true then the would never have passed sec scrutiny and got their form 10! https://www.sec.gov/Archives/edgar/data/1382943/000000000019009260/filename2.txt
Revenues growing q over q! I’m assuming this Q will be the same.
IQVIA (multi billion dollar company) leading one of their fda trials http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
Major partnership with ThermoFisher
It’s hard to look at but this will all wash out and company will uplist and get it’s true value point when the big boys come in. Right now it’s easy to scare retail investors and this was their last chance and they took it. It’s shitty and unfair but it’s the way the market works.
As I always say, do your homework and know what you own
All the recent press and it’s extensive
http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/
http://predtechgroup.com/2019/06/predictive-technology-group-names-industry-veteran-dr-douglas-rabin-vice-president-of-medical-affairs-womens-health-of-predictive-laboratories/
http://predtechgroup.com/2019/05/predictive-technology-group-announces-enrollment-milestone-of-200-participants-in-predictive-laboratories-study-for-chronic-joint-and-spine-pain/
http://predtechgroup.com/2019/04/predictive-technology-group-names-christine-seward-senior-vice-president-of-sales-and-marketing-of-predictive-laboratories/
http://predtechgroup.com/press/
Just an FYI but the price has to be above $2 for 5 days but to be honest I don’t feel it’s important. Company will go to nasdaq at some point. What’s more important is executing on the fundamentals which I believe they are.
Everything else will follow. This is a fundamental that will return huge rewards if you show a bit of patience’s. We all want news weekly but the company is executing to a much bigger plan